Does Emgality Work for Cluster Headaches?
Emgality (galcanezumab), a CGRP monoclonal antibody, is FDA-approved only for episodic and chronic migraine prevention in adults, not for cluster headaches.[1] Clinical trials and labeling exclude cluster headache data, focusing solely on migraine reduction (e.g., 50% fewer migraine days per month in trials).[1][2]
Why Not Approved for Cluster Headaches?
Cluster headaches differ mechanistically from migraines despite some symptom overlap like severe pain. Emgality targets CGRP, elevated in migraines, but cluster headaches involve the trigeminal-autonomic reflex and hypothalamic activation, with less clear CGRP involvement.[3] No pivotal trials tested it here; approval requires specific efficacy data under FDA rules.[1]
Any Evidence from Studies or Real-World Use?
Small case reports and open-label studies show mixed results. A 2020 case series of 5 patients with chronic cluster headaches found partial response in 2 (attack reduction), no benefit in 3.[4] A 2022 retrospective review of 12 patients reported 40% had fewer attacks, but most relapsed after 3-6 months.[5] No randomized controlled trials exist; experts call evidence anecdotal and insufficient for recommendation.[3][6] Off-label use occurs rarely due to high cost (~$700/month) and lack of insurance coverage.[7]
How Does It Compare to Proven Cluster Treatments?
| Treatment | Type | Approval for Cluster | Efficacy Notes |
|-----------|------|----------------------|---------------|
| Emgality | CGRP inhibitor (preventive) | No | Limited, inconsistent off-label data [4][5] |
| Emgality | Verapamil | Preventive (first-line) | Reduces attacks in 70-80% of episodic cases [3] |
| Oxygen | Acute | Yes | Aborts 70-90% attacks in 15 min [3] |
| Galcanezumab | Emgality (injectable monthly) | No | - |
| Zolmitriptan nasal | Acute | Yes | Faster for some vs. sumatriptan [3] |
For prevention, verapamil or galcanezumab (not Emgality) show stronger data; galcanezumab had a failed Phase 2 trial for episodic cluster.[6]
What Do Guidelines Say?
American Headache Society and European guidelines do not list Emgality for cluster headaches, citing insufficient evidence.[3][8] Neurologists advise against routine off-label use; try verapamil, lithium, or topiramate first.[3]
Patient Experiences and Risks
Online forums (e.g., Clusterbusters) report rare success stories but frequent failures and side effects like injection-site reactions, constipation, or hypersensitivity.[9] Risks mirror migraines: rare anaphylaxis. No long-term cluster-specific safety data.[1] Consult a headache specialist; insurance rarely covers off-label.
[1]: FDA Emgality Label
[2]: NEJM Trial (2017)
[3]: AHS Position Statement
[4]: Headache Journal Case Series (2020)
[5]: J Neurol (2022)
[6]: Lancet Neurology Review (2021)
[7]: GoodRx Pricing
[8]: EFNS Guidelines
[9]: Clusterbusters.org forums (patient reports, 2023)